Highly Efficient Synthesis of HIV NNRTI Doravirine
作者:Donald R. Gauthier、Benjamin D. Sherry、Yang Cao、Michel Journet、Guy Humphrey、Tetsuji Itoh、Ian Mangion、David M. Tschaen
DOI:10.1021/ol503625z
日期:2015.3.20
The development of an efficient and robust process for the production of HIV NNRTI doravirine is described. The synthesis features a continuous aldol reaction as part of a de novo synthesis of the key pyridone fragment. Conditions for the continuous flow aldol reaction were derived using microbatch snapshots of the flow process.
[EN] PROCESS FOR MAKING REVERSE TRANSCRIPTASE INHIBITORS<br/>[FR] PROCÉDÉ DE PRÉPARATION D'INHIBITEURS DE TRANSCRIPTASE INVERSE
申请人:MERCK SHARP & DOHME
公开号:WO2014089140A1
公开(公告)日:2014-06-12
The present invention is directed to a novel process for synthesizing 3-(substituted phenoxy)-1-[(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl])-pyridin-2(1H)-one derivatives. The compounds synthesized by the processes of the invention are HIV reverse transcriptase inhibitors useful for inhibiting reverse transcriptase, HIV replication and the treatment of human immunodeficiency virus infection in humans.